| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $165.5M | -1.0% |
| SG&A Expense | $30.7M | +73.2% |
| Operating Income | -$196.2M | -6.1% |
| Pre-tax Income | -$195.3M | -5.6% |
| Income Tax | $12.2M | +149.0% |
| Net Income | -$207.4M | -9.3% |
| EPS (Basic) | -$12.43 | -9.3% |
| EPS (Diluted) | -$12.43 | -9.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $270.9M | — |
| Current Assets | $277.3M | +5657.5% |
| Total Assets | $301.7M | +794.1% |
| Current Liabilities | $29.0M | -30.2% |
| Total Liabilities | $37.9M | -31.5% |
| Stockholders' Equity | $263.8M | +1318.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$194.2M | -15.2% |
| Capital Expenditures | $3.5M | -37.4% |
| Investing Cash Flow | -$3.5M | +37.4% |
| Financing Cash Flow | $468.8M | +169.3% |
| Free Cash Flow | -$197.7M | -13.6% |